LEADER 02506nam 2200589Ia 450 001 9910457141703321 005 20200520144314.0 010 $a1-282-78743-8 010 $a9786612787430 010 $a0-309-15187-2 035 $a(CKB)2550000000027553 035 $a(EBL)3378647 035 $a(SSID)ssj0000423782 035 $a(PQKBManifestationID)11276749 035 $a(PQKBTitleCode)TC0000423782 035 $a(PQKBWorkID)10440987 035 $a(PQKB)11282796 035 $a(MiAaPQ)EBC3378647 035 $a(Au-PeEL)EBL3378647 035 $a(CaPaEBR)ebr10405112 035 $a(CaONFJC)MIL278743 035 $a(OCoLC)611632162 035 $a(EXLCZ)992550000000027553 100 $a20100803d2010 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 12$aA national cancer clinical trials system for the 21st century$b[electronic resource] $ereinvigorating the NCI cooperative group program /$fCommittee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services 210 $aWashington, D.C. $cNational Academies Press$dc2010 215 $a1 online resource (317 p.) 300 $aDescription based upon print version of record. 311 $a0-309-15186-4 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Reviewers""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""Overview of Conclusions and Recommendations""; ""1 Introduction""; ""2 The Science of Developing Cancer Therapy""; ""3 Operations, Oversight, and Funding of Cancer Clinical Trials""; ""4 Physician and Patient Participation in Cancer Clinical Trials""; ""Appendix A: Previous and Ongoing Analyses Undertaken by NCI""; ""Appendix B: Committee Member and Staff Biographies""; ""Acronyms""; ""Glossary"" 606 $aClinical trials$zUnited States 606 $aCancer$xResearch$zUnited States 608 $aElectronic books. 615 0$aClinical trials 615 0$aCancer$xResearch 676 $a616.9940072 712 02$aNational Academies Press (U.S.) 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Care Services. 712 02$aNCI Cooperative Group Program (National Cancer Institute) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910457141703321 996 $aA national cancer clinical trials system for the 21st century$92491501 997 $aUNINA